213 related articles for article (PubMed ID: 29851220)
1. Dexmedetomidine protects hepatic cells against oxygen-glucose deprivation/reperfusion injury via lncRNA CCAT1.
Zhou Z; Chen Q; Wan L; Zheng D; Li Z; Wu Z
Cell Biol Int; 2018 Sep; 42(9):1250-1258. PubMed ID: 29851220
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.
Liu C; Xu R
Bioengineered; 2022 May; 13(5):13300-13311. PubMed ID: 35635079
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
Wang K; Zhu Y
J Int Med Res; 2018 Feb; 46(2):675-686. PubMed ID: 29210287
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy.
Fu Z; Pang Z; He L; Zhang L; Fan Y; Zhao C; Yang J
Neurochem Res; 2022 Nov; 47(11):3490-3505. PubMed ID: 36042140
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
Yuan M; Meng XW; Ma J; Liu H; Song SY; Chen QC; Liu HY; Zhang J; Song N; Ji FH; Peng K
Drug Des Devel Ther; 2019; 13():3137-3149. PubMed ID: 31564830
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis.
Chen Y; Fan Z; Wu Q
Bioengineered; 2021 Dec; 12(1):4794-4804. PubMed ID: 34334080
[TBL] [Abstract][Full Text] [Related]
8. Suppression of lncRNA RMRP ameliorates oxygen-glucose deprivation/re-oxygenation-induced neural cells injury by inhibiting autophagy and PI3K/Akt/mTOR-mediated apoptosis.
Zhou Z; Xu H; Liu B; Dun L; Lu C; Cai Y; Wang H
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 30926681
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway.
Feng P; Zhang A; Su M; Cai H; Wang X; Zhang Y
Brain Res; 2021 Jan; 1750():147141. PubMed ID: 33017590
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy.
Shao Q; Xia J; Wu P; Ying J
Microcirculation; 2021 May; 28(4):e12675. PubMed ID: 33377581
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells.
Luo C; Yuan D; Yao W; Cai J; Zhou S; Zhang Y; Hei Z
Life Sci; 2015 Feb; 122():72-7. PubMed ID: 25529146
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CCAT1 Protects Astrocytes Against OGD/R-Induced Damage by Targeting the miR-218/NFAT5-Signaling Axis.
Xia X; Niu H; Ma Y; Qu B; He M; Yu K; Wang E; Zhang L; Gu J; Liu G
Cell Mol Neurobiol; 2020 Nov; 40(8):1383-1393. PubMed ID: 32239388
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOXA11-AS regulates ischemic neuronal death by targeting miR-337-3p/YBX1 signaling pathway: protective effect of dexmedetomidine.
Yan F; Wang P; Yang X; Wang F
Aging (Albany NY); 2023 Apr; 15(7):2797-2811. PubMed ID: 37059588
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine alleviates ferroptosis following hepatic ischemia-reperfusion injury by upregulating Nrf2/GPx4-dependent antioxidant responses.
Zhang Y; Wei H; Wang M; Yu Y; Gu M; Zhong H; Dong S
Biomed Pharmacother; 2023 Dec; 169():115915. PubMed ID: 38000361
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress dependent apoptosis through the PERK-CHOP-Caspase-11 pathway.
Liu C; Fu Q; Mu R; Wang F; Zhou C; Zhang L; Yu B; Zhang Y; Fang T; Tian F
Brain Res; 2018 Dec; 1701():246-254. PubMed ID: 30201260
[TBL] [Abstract][Full Text] [Related]
16. MiR-29b expression is associated with a dexmedetomidine-mediated protective effect against oxygen-glucose deprivation-induced injury to SK-N-SH cells in vitro.
Huang Z; Liu G; Zeng Q; Gao R; Zhang S; Wang L; Liu B; Yu Y; Zhao A; Li R; Zhou S; Yu W
Cell Biol Int; 2018 Mar; 42(3):344-352. PubMed ID: 29087603
[TBL] [Abstract][Full Text] [Related]
17. YY1/LncRNA GAS5 complex aggravates cerebral ischemia/reperfusion injury through enhancing neuronal glycolysis.
Zhang XC; Gu AP; Zheng CY; Li YB; Liang HF; Wang HJ; Tang XL; Bai XX; Cai J
Neuropharmacology; 2019 Nov; 158():107682. PubMed ID: 31278927
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine protects liver cell line L-02 from oxygen-glucose deprivation-induced injury by down-regulation of microRNA-711.
Zhu YX; Zhou JH; Li GW; Zhou WY; Ou SS; Xiao XY
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6507-6516. PubMed ID: 30338821
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates oxygen-glucose deprivation/ reperfusion-induced inflammation through the miR-17-5p/ TLR4/ NF-κB axis.
Suo L; Wang M
BMC Anesthesiol; 2022 Apr; 22(1):126. PubMed ID: 35488217
[TBL] [Abstract][Full Text] [Related]
20. The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis.
Lin J; Huang HF; Yang SK; Duan J; Qu SM; Yuan B; Zeng Z
Biomed Pharmacother; 2020 Sep; 129():110398. PubMed ID: 32603889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
